Back to Portfolio
Dolcinac-MR Gel
Dolcinac-MR Gel

Scientific Formulation

Dolcinac-MR Gel

The next generation in transdermal therapy. Powered by proprietary EXCEDERM™ Technology, Dolcinac-MR Gel is specifically engineered to overcome the skin's natural stratum corneum barrier, delivering active ingredients deep into the muscle tissue where conventional gels fail to penetrate.

Molecular Composition

Diclofenac Diethylamine 1.16% w/w + Thiocolchicoside 0.125% w/w + Linseed Oil + Methyl Salicylate + Menthol

Therapeutic Matrix

  • EXCEDERM™ Barrier Penetration
  • Extra-Powerful Thio-Gel
  • 66% Higher Transdermal Flux
  • Biphasic Permeation Enhancement

Mechanisms of Action

EXCEDERM™ Technology

Induces alteration in skin membrane dynamics via lipid extraction and keratin interaction to allow deep drug delivery.

Thiocolchicoside 0.125%

A potent muscle relaxant effective at lower concentrations due to its high-permeation biphasic mode.

Diclofenac Diethylamine

Optimized for high flux (37.55 g/cm²/hr), significantly outperforming conventional topical technologies.

Multi-Essential Matrix

Combines Linseed Oil, Menthol, and Methyl Salicylate to provide rapid cooling and prolonged therapeutic effect.

Clinical Advantage

Proprietary barrier-bypassing technology ensures that the 'Extra Powerful Thio Gel' reaches its target with surgical precision and maximum efficacy.

Precision Healthcare for Everyone

BrandBrand